AICDA and rheumatoid arthritis: Comparative analysis of seropositivity rates among HC and AID subgroups demonstrated similar results for RA, SSC, and SS; however, lower seropositivity rates were observed in SpA (73%, p = 0.02) and SLE (73%, p = 0.03) relative to HC.